Prior SARS‐CoV‐2 infection and COVID‐19 vaccine effectiveness against outpatient illness during widespread circulation of SARS‐CoV‐2 Omicron variant, US Flu VE network is a research paper published in Influenza and Other Respiratory Viruses (2023). On theSindex it has a DataRank of 0. It has been cited 19 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Center for Advancing Translational Sciences
Grant: 5UL1TR002243‐03
National Center for Immunization and Respiratory Diseases
Grant: 75D30121C11513
National Center for Immunization and Respiratory Diseases
Grant: 75D30121C11519
National Center for Immunization and Respiratory Diseases
Grant: 75D30121C11529
National Center for Immunization and Respiratory Diseases
Grant: 75D30121C11909
National Center for Immunization and Respiratory Diseases
Grant: 75D30121C12246
National Center for Immunization and Respiratory Diseases
Grant: 75D30121C12279
National Center for Immunization and Respiratory Diseases
Grant: 75D30121C12339
National Institutes of Health
Grant: UL1TR001857
National Institutes of Health
Grant: 5UL1TR002243-05
Vanderbilt Institute for Clinical and Translational Research (VICTR)
National Institutes of Health
Grant: 3UL1TR001857-07S1
University of Pittsburgh Clinical and Translational Science Institute
National Institutes of Health
Grant: 5UL1TR002243-03
Vanderbilt Institute for Clinical and Translational Research (VICTR)
Fields of Study
Keywords
Sustainable Development Goals